Company / Accounts Receivable
MESA LABORATORIES INC /CO/ Accounts Receivable History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$44.1M
FY2026
5-year range
$39.1M / $44.1M
FY2022-FY2026
Trend
+5.1%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has fluctuated over the past 10 years, ranging from $13M in FY2019 to $44M in FY2026.
Based on SEC 10-K filings.
$44M in FY2026 with a 5-year CAGR of +13.1%.
Improved from $39M to $44M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +1.2%
- 5-Year CAGR
- +13.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +13.1%, indicating consistent growth.
- In FY2026, accounts receivable increased 5.1% year-over-year.
- Lowest accounts receivable in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.03 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $44.1M | +5.1% |
| FY2025 | $42.0M | +7.5% |
| FY2024 | $39.1M | -8.2% |
| FY2023 | $42.6M | +3.2% |
| FY2022 | $41.2M | +73.3% |
| FY2021 | $23.8M | +12.6% |
| FY2020 | $21.1M | +68.8% |
| FY2019 | $12.5M | -12.5% |
| FY2018 | $14.3M | -0.1% |
| FY2017 | $14.3M | -6.5% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026